WelcomeUser Guide
ToSPrivacyCanary
DonateBugsLicense

©2025 Poal.co

1.0K

>bioRxiv is receiving many new papers on coronavirus SARS-CoV-2. A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. https://www.biorxiv.org/content/10.1101/2020.09.08.280818v1.full

100 bucks says every MSM outlet uses this garbage non-peer reviewed study on the effectiveness of the BNT162b2 gene therapy as god's word. Now I'm off to discover if Pfizer solved the Antigen Dependency Enhancement problem which has plagued coronavirus animal trials in the past. That's why we've never been to successfully vaccinate against the cold. The animals vaccinated die from ADE. Where are these macaques now?

>>bioRxiv is receiving many new papers on coronavirus SARS-CoV-2. A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. https://www.biorxiv.org/content/10.1101/2020.09.08.280818v1.full 100 bucks says every MSM outlet uses this garbage non-peer reviewed study on the effectiveness of the BNT162b2 gene therapy as god's word. Now I'm off to discover if Pfizer solved the Antigen Dependency Enhancement problem which has plagued coronavirus animal trials in the past. That's why we've never been to successfully vaccinate against the cold. The animals vaccinated die from ADE. Where are these macaques now?

(post is archived)

[–] [deleted] 2 pts

Wasn't one study using ferrets? Have yet to hear of any animals who were testing surviving....

[–] 1 pt

Found another one.

>*Important Notice medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information. https://www.news-medical.net/news/20200823/PfizerBioNTech-COVID-19-vaccine-candidate-BNT162b2-profiled-for-large-scale-clinical-trials.aspx

[–] 0 pt
[–] 0 pt
[–] 0 pt

They think they can solve it it they make the vax super strong (2 doses, high immunogenicity) and force everyone to take it. Then they think they can wipe it out and prevent an ADE variant (a variant able to effectively evade the antibodies from the vax) from developing and killing everyone.

Actually I think that the people most vulnerable to ADE are young people with vigorous immune systems.

And since everyone who gets the vax will be immune to the same specific early strain, everyone who gets the vax may be vulnerable to a single pro-ADE variant which could spread really fast, unless they get boosters for variants.

I dont feel confident at all on the ADE subject but this is what I think their strategy is.

I guess time will tell.